Conference Details

The seminar will mainly focus on critical points related to clinical trials. Among the others, a critical point is related to the clinical trial endpoints, other than survival, that objectively demonstrate meaningful clinical benefit. In fact, with the introduction of molecular pathology, patients and their oncologists now deal with a greater variety of malignant diseases than ever before, each of which likely benefits from a unique approach to treatment. Furthermore, many new drugs determine slow tumor progression instead of causing tumor shrinkage.

Date :

Place : United States, Philadelphia, pa

Website :

Contact Person:Roger Steven

Description:

The seminar will mainly focus on critical points related to clinical trials. Among the others, a critical point is related to the clinical trial endpoints, other than survival, that objectively demonstrate meaningful clinical benefit. In fact, with the introduction of molecular pathology, patients and their oncologists now deal with a greater variety of malignant diseases than ever before, each of which likely benefits from a unique approach to treatment. Furthermore, many new drugs determine slow tumor progression instead of causing tumor shrinkage.

The seminar will mainly focus on critical points related to clinical trials. Among the others, a critical point is related to the clinical trial endpoints, other than survival, that objectively demonstrate meaningful clinical benefit. In fact, with the introduction of molecular pathology, patients and their oncologists now deal with a greater variety of malignant diseases than ever before, each of which likely benefits from a unique approach to treatment. Furthermore, many new drugs determine slow tumor progression instead of causing tumor shrinkage. will be held in Philadelphia, pa,United States on date 2014-10-10

Deadline for abstracts/proposals : 7th October 2014

Organized By :MentorHealth

Keynote Speakers :

Check the for more details.

Views: 2836

Venue - Map & Directions